One of the most detailed maps to date of meningioma—the most common brain tumor in adults—reveals how the tumor’s surrounding environment helps drive disease behavior and patient outcomes, according to new research from Mayo Clinic.
A blood test could map the complex ecosystem surrounding cancer cells, offering a more accurate way to predict which patients will benefit from immunotherapy, according to researchers at Mayo Clinic and Stanford Medicine. The test they developed could help guide treatment decisions across multiple cancer types and treatments.
